SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-21-053983
Filing Date
2021-08-30
Accepted
2021-08-30 20:13:44
Documents
1
Period of Report
2021-08-30

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 4132
  Complete submission text file 0001209191-21-053983.txt   5602
Mailing Address 4955 DIRECTORS PLACE SAN DIEGO CA 92121
Business Address 4955 DIRECTORS PLACE SAN DIEGO CA 92121 858-203-4100
Sorrento Therapeutics, Inc. (Issuer) CIK: 0000850261 (see all company filings)

IRS No.: 330344842 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O SORRENTO THERAPEUTICS, INC. 4955 DIRECTOR'S PLACE SAN DIEGO CA 92121
Business Address
Lemus David (Reporting) CIK: 0001717972 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36150 | Film No.: 211225138